Indicator opportunistic infections after biological treatment in rheumatoid arthritis, 10 years follow-up in a real-world setting

Background: This research describes the incidence and factors associated with opportunistic infections in rheumatoid arthritis (RA) patients treated with biological disease-modifying antirheumatic drugs (bDMARDs). Methods: A retrospective longitudinal study was carried out from 2007 to 2018. We incl...

Full description

Bibliographic Details
Main Authors: Leticia Leon, Marina Peñuelas, Francisco Javier Candel, Dalifer Freites, Luis Rodriguez-Rodriguez, Benjamin Fernandez-Gutierrez, Juan Angel Jover, Lydia Abasolo
Format: Article
Language:English
Published: SAGE Publishing 2019-10-01
Series:Therapeutic Advances in Musculoskeletal Disease
Online Access:https://doi.org/10.1177/1759720X19878004